Agilent Technologies Inc. has announced that it has signed a definitive agreement to acquire privately-owned ACEA Biosci...
Singapore - Fullerton Healthcare Corporation Limited, a leading vertically integrated healthcare platform in the As...
China's biopharma firm Changchun High & New Technology Industries have teamed up with Iceland's drugmaker Alvotech t...
Researchers from Jinan University in China have developed a smart photoacoustic imaging approach by using a combination ...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...
CPhI Worldwide the world’s largest pharma event taking place in Madrid (9-11, October 2018) and org...
Huami Corporation, a biometric and activity data-driven company with significant expertise in smart wearable technology,...
Agendia, Inc., a world leader in precision oncology has announced that it has entered into an exclusive commercial partn...
Global growth equity firm General Atlantic has invested $150 million in Chinese healthcare services provider and hospita...
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly...
Genecast Biotechnology Co. Ltd. has announced it has just reached strategic partnership agreement with the global leader...
A new agreement has been signed between the Fijian and Chinese governments that will see the construction of a health an...
Shuwen Biotech is the first in China to launch a locally manufactured proprietary PD-L1 test kit, which can accurately d...
Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia ...
EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, has ...
This year at the Eastern Economic Forum in Vladivostok, BIOCAD and Shanghai Pharmaceuticals Holding entered into a Memor...
A recent circular issued by the Chinese State Drug Administration (SDA), has opened up a large market for Contract Resea...
WuXi Biologics (2269.HK, WuXi Bio), a leading global open-access biologics technology platform company offering end-to-e...
